These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10037169)

  • 21. The role of immunotherapy in the treatment of colorectal cancer.
    Reddy GK
    Clin Colorectal Cancer; 2006 Jan; 5(5):324-6. PubMed ID: 16512990
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant immunotherapy for melanoma and colorectal cancers.
    Safa MM; Foon KA
    Semin Oncol; 2001 Feb; 28(1):68-92. PubMed ID: 11254868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
    Conry RM; Allen KO; Lee S; Moore SE; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2000 Jan; 6(1):34-41. PubMed ID: 10656429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapy of colorectal cancer--overview and perspectives].
    Schimanski CC; Hörner V; Kanzler S; Galle PR; Moehler M
    Z Gastroenterol; 2006 Aug; 44(8):673-81. PubMed ID: 16902899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer.
    Dziki A
    Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibilities of immunotherapy of colorectal cancers and pancreatic tumors].
    Klapdor R
    Z Gastroenterol Verh; 1991 Mar; 26():220-7. PubMed ID: 1714155
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological therapy of colorectal cancer.
    de Kleijn EM; Punt CJ
    Eur J Cancer; 2002 May; 38(7):1016-22. PubMed ID: 11978526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.
    Maxwell-Armstrong C
    Ann R Coll Surg Engl; 2002 Sep; 84(5):314-8. PubMed ID: 12398121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current immunotherapeutic strategies in colon cancer.
    Morse M; Langer L; Starodub A; Hobeika A; Clay T; Lyerly HK
    Surg Oncol Clin N Am; 2007 Oct; 16(4):873-900, x. PubMed ID: 18022550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
    Samonigg H; Wilders-Truschnig M; Kuss I; Plot R; Stöger H; Schmid M; Bauernhofer T; Tiran A; Pieber T; Havelec L; Loibner H
    J Immunother; 1999 Nov; 22(6):481-8. PubMed ID: 10570746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human vaccines & immunotherapeutics: news.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Jul; 9(7):1395-8. PubMed ID: 23863285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotype vaccine in colorectal cancer patients.
    Herlyn D; Zaloudik J; Somasundaram R; Jacob L; Benden A; Mastangelo M
    Hybridoma; 1993 Oct; 12(5):515-20. PubMed ID: 8300124
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody.
    Kim JA; Bresler HS; Martin EW; Aldrich W; Heffelfinger M; Triozzi PL
    Cancer; 1999 Jul; 86(1):22-30. PubMed ID: 10391559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
    Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10256-60. PubMed ID: 11517330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New vaccine to fight colorectal cancer.
    Kerr C
    Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17354305
    [No Abstract]   [Full Text] [Related]  

  • 37. A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.
    Durrant LG; Maxwell-Armstrong C; Buckley D; Amin S; Robins RA; Carmichael J; Scholefield JH
    Clin Cancer Res; 2000 Feb; 6(2):422-30. PubMed ID: 10690519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
    Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
    Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside.
    Mocellin S
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.